Menu Search
Equities

LifeVantage Corp

LFVN:NAQ

LifeVantage Corp

Actions
Consumer Staples Food Producers
  • Price (USD)13.66
  • Today's Change-0.11 / -0.80%
  • Shares traded68.66k
  • 1 Year change+89.20%
  • Beta0.8519
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year LifeVantage Corp had revenues fall -6.20% from 213.40m to 200.16m, though the company grew net income 15.63% from 2.54m to 2.94m.
Gross margin79.21%
Net profit margin2.11%
Operating margin3.14%
Return on assets6.46%
Return on equity14.51%
Return on investment10.17%
More ▼

Cash flow in USDView more

In 2024, cash reserves at LifeVantage Corp fell by 4.72m. However, the company earned 12.20m from its operations for a Cash Flow Margin of 6.09%. In addition the company used 2.25m on investing activities and also paid 14.42m in financing cash flows.
Cash flow per share0.5917
Price/Cash flow per share22.53
Book value per share2.22
Tangible book value per share2.20
More ▼

Balance sheet in USDView more

LifeVantage Corp uses little or no debt in its capital structure.
Current ratio1.76
Quick ratio0.9923
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 16.00% and 11.90%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)46.11%
EPS growth(5 years)-14.53
EPS (TTM) vs
TTM 1 year ago		59.97
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.